Additionally, the presence of ER-β in dysplastic lesions as well as in melanoma in situ may suggest the importance of the 17β-estradiol/ER-β pathway in the proliferation and transformation of melanocytes [32]. The gene discussed is ESR2; the disease is melanoma.